Related references
Note: Only part of the references are listed.Small-Molecule Inhibitors of the ERK Signaling Pathway: Towards Novel Anticancer Therapeutics
Jeremy L. Yap et al.
CHEMMEDCHEM (2011)
Eriodictyol Inhibits RSK2-ATF1 Signaling and Suppresses EGF-induced Neoplastic Cell Transformation
Kangdong Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
A Regulatory Mechanism for RSK2 NH2-Terminal Kinase Activity
Yong-Yeon Cho et al.
CANCER RESEARCH (2009)
Cyclin-Dependent Kinase-3-Mediated c-Jun Phosphorylation at Ser63 and Ser73 Enhances Cell Transformation
Yong-Yeon Cho et al.
CANCER RESEARCH (2009)
Selectivity and therapeutic inhibition of kinases: to be or not to be?
Kamran Ghoreschi et al.
NATURE IMMUNOLOGY (2009)
Extracts of Magnoliae flos inhibit inducible nitric oxide synthase via ERK in human respiratory epithelial cells
Jin Ah Baek et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2009)
Role of a cysteine residue in the active site of ERK and the MAPKK family
Makoto Ohori et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Ribosomal s6 kinase 2 is a key regulator in tumor promoter-induced cell transformation
Yong-Yeon Cho et al.
CANCER RESEARCH (2007)
Effects of MAP kinase inhibitors on epidermal growth factor-induced neoplastic transformation of human keratinocytes
H Mizuno et al.
MOLECULAR CARCINOGENESIS (2006)
Identification of a selective ERK inhibitor and structural determination of the inhibitor-ERK2 complex
M Ohori et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
The p53 protein is a novel substrate of ribosomal S6 kinase 2 and a critical intermediary for ribosomal S6 kinase 2 and histone H3 interaction
YY Cho et al.
CANCER RESEARCH (2005)
Kinomics-structural biology and chemogenomics of kinase inhibitors and targets
M Vieth et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2004)
Targeting the mitogen-activated protein kinase cascade to treat cancer
JS Sebolt-Leopold et al.
NATURE REVIEWS CANCER (2004)
ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions
PP Roux et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2004)
A novel role for mixed-lineage kinase-like mitogen-activated protein triple kinase a in neoplastic cell transformation and tumor development
YY Cho et al.
CANCER RESEARCH (2004)
Development of anticancer drugs targeting the MAP kinase pathway
JS Sebolt-Leopold
ONCOGENE (2000)
A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1
M Frödin et al.
EMBO JOURNAL (2000)
Share Paper
